tanshinone has been researched along with darunavir in 1 studies
Studies (tanshinone) | Trials (tanshinone) | Recent Studies (post-2010) (tanshinone) | Studies (darunavir) | Trials (darunavir) | Recent Studies (post-2010) (darunavir) |
---|---|---|---|---|---|
1,445 | 10 | 1,033 | 1,148 | 224 | 780 |
Protein | Taxonomy | tanshinone (IC50) | darunavir (IC50) |
---|---|---|---|
Chain A, HIV-1 protease | Human immunodeficiency virus 1 | 0.0028 | |
Chain B, HIV-1 protease | Human immunodeficiency virus 1 | 0.0028 | |
Chain A, HIV-1 protease | Human immunodeficiency virus 1 | 0.0028 | |
Chain B, HIV-1 protease | Human immunodeficiency virus 1 | 0.0028 | |
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 6.6 | |
Protease | Human immunodeficiency virus 1 | 0.063 | |
Protease | Human immunodeficiency virus 1 | 0.0014 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
1 other study(ies) available for tanshinone and darunavir
Article | Year |
---|---|
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |